HOME >> BIOLOGY >> NEWS
New drug target and biomarker for advanced childhood cancer discovered

Scientists announced today that they have discovered a protein produced by advanced childhood cancers that provides a new target for treatments and a new marker for the disease. Separately, researchers reported data on the crystal structures of two kinase proteins implicated in multiple cancers. The data on structure provides valuable information for the design of cancer therapeutics targeted at these proteins. The studies were presented today at the International Conference on Molecular Targets and Cancer Therapeutics organized by the American Association of Cancer Research (AACR), National Cancer Institute (NCI) and European Organisation for Research and Treatment of Cancer (EORTC) in Boston.

Identification of a novel secretory protein specific to neuroblastoma: Abstract 1216

A new protein found only in the cells of neuroblastoma, a common childhood cancer, could provide clues to differentiating between aggressive tumors and those that are more likely to respond to treatment, said Baylor College of Medicine researchers who discovered it.

The gene that codes for the protein, called neuroblastoma-derived secreted protein or NDSP, is most active in severe cases of neuroblastoma, said Dr. Jianhua Yang, assistant professor of pediatrics/hematology and oncology, at Baylor College of Medicine in Houston. As such, the protein could provide important information about the recurrence of disease after first treatment, said Dr. Jed Nuchtern, associate professor of pediatrics/surgery at Baylor College of Medicine.

"We know there are some tumor cells left after surgery and chemotherapy because of the high relapse rate," Dr. Nuchtern said. "This gene may make possible a sensitive means of detecting those."

Dr. Yang discovered the gene, a novel structure, during a screening using microarray technology. He subsequently discovered the gene was only expressed in neuroblastoma cells. So far, Dr. Yang has only tested neuroblastoma cell lines
'"/>

Contact: Warren Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
19-Nov-2003


Page: 1 2 3

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. Safety of isoflavones in dietary supplements targeted by Illinois initiative
3. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
4. Evidence builds for potential new cancer drug target
5. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
6. Images of tail of protein needed for cell multiplication suggest anticancer drug targets
7. Diabodies act as guided missiles targeted to mammary tumor growth
8. Anticancer drug zebularine specifically targets tumor cells
9. Study suggests cell-cycle triggers might be cancer drug targets
10. Sweet success in targeting sugar molecules to cells in living animals
11. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: